Results 201 to 210 of about 112,037 (251)

Early On‐Treatment Change in SALT as a Pragmatic Predictor of Ritlecitinib Response in Moderate‐To‐Severe Alopecia Areata: A Real‐World Cohort Study

open access: yesInternational Journal of Dermatology, EarlyView.
Ritlecitinib induced rapid clinical improvement in moderate‐to‐severe alopecia areata in real‐world practice. Early change in SALT at Week 12 strongly discriminated Week‐24 responders, supporting a pragmatic treat‐to‐target checkpoint, alongside improvements in clinician‐reported and patient‐reported outcomes and a favorable safety profile.
Giuseppe Gallo   +4 more
wiley   +1 more source

Clinical Outcomes of Children With Autoimmune Hepatitis in Korea: A Nationwide Multicenter Study. [PDF]

open access: yesJ Korean Med Sci
Ahn JE   +16 more
europepmc   +1 more source

Second-line tacrolimus and mycophenolate mofetil in difficult-to-treat autoimmune hepatitis. [PDF]

open access: yesHepatol Commun
Laschtowitz A   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy